Assessing possible celiac disease by an HLA-DQ2-gliadin tetramer test

American Journal of Gastroenterology

Volumn 106, Issue 7, 2011, Pages 1318-1324

  Brottveit, Margit ^a   Ráki, Melinda ^b   Bergseng, Elin ^b   Fallang, Lars Egil ^b   Simonsen, Bjørg ^b   Løvik, Astrid ^c   Larsen, Stig ^d   Løberg, Else Marit ^a   Jahnsen, Frode L ^b,c   Sollid, Ludvig M ^b   Lundin, Knut E A ^b,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; GLUTEN; HLA DQ2 ANTIGEN; TETRAMER;

ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DUODENUM; DUODENUM BIOPSY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FLOW CYTOMETRY; FOOD ALLERGY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; PROVOCATION TEST; STAINING; T LYMPHOCYTE; TETRAMER TEST;

EID: 79960073170     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.23     Document Type: Article

References (36)

1. Madsen C. Prevalence of food allergy: an overview. Proc Nutr Soc 2005; 64: 413-7. (Pubitemid 41705440)
2. Jansen JJ, Kardinaal AF, Huijbers G et al. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol 1994; 93: 446-56. (Pubitemid 24081785)
3. Zuberbier T, Edenharter G, Worm M et al. Prevalence of adverse reactions to food in Germany-a population study. Allergy 2004; 59: 338-45. (Pubitemid 38339853)
4. Kagnoff MF. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006; 131: 1977-80. (Pubitemid 44958522)
5. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005; 3: 843-51. (Pubitemid 41222309)
6. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11.
7. Hill ID, Dirks MH, Liptak GS et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19. (Pubitemid 40180049)
8. Inomata N. Wheat allergy. Curr Opin Allergy Clin Immunol 2009; 9: 238-43.
9. Kaukinen K, Turjanmaa K, Maki M et al. Intolerance to cereals is not specific for coeliac disease. Scand J Gastroenterol 2000; 35: 942-6.
10. Campanella J, Biagi F, Bianchi PI et al. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol 2008; 43: 1311-4.
11. Wahnschaffe U, Schulzke JD, Zeitz M et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007; 5: 844-50. (Pubitemid 47031067)
12. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the " no man's land " of gluten sensitivity. Am J Gastroenterol 2009; 104: 1587-94.
13. Springen K. A new diet villain. Newsweek. 3-12-2008.
14. Copelton DA, Valle G. "You don't need a prescription to go gluten-free ": the scientific self-diagnosis of celiac disease. Soc Sci Med 2009; 69: 623-31.
15. Anderson RP, Degano P, Godkin AJ et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000; 6: 337-42. (Pubitemid 30148628)
16. Anderson RP, van Heel DA, Tye-Din JA e t al. Tcells in peripheral blood aft er gluten challenge in coeliac disease. Gut 2005; 54: 1217-23. (Pubitemid 41192478)
17. Raki M, Fallang LE, Brottveit M et al. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci USA 2007; 104: 2831-6. (Pubitemid 46327965)
18. Sugai E, Nachman F, Vaquez H et al. Dynamics of celiac disease-specific serology aft er initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis 2010; 42: 352-8.
19. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-94. (Pubitemid 30433773)
20. Quarsten H, McAdam SN, Jensen T et al. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol 2001; 167: 4861-8. (Pubitemid 33009714)
21. Sollid LM, Lundin KE. Diagnosis and treatment of celiac disease. Mucosal Immunol 2009; 2: 3-7.
22. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2: 647-55. (Pubitemid 37328722)
23. Green PH, Jabri B. Celiac disease. Annu Rev Med 2006; 57: 207-21. (Pubitemid 43261988)
24. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187-96. (Pubitemid 23173254)
25. Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94-6. (Pubitemid 26332731)
26. Kwok WW, Ptacek NA, Liu AW et al. Use of class II tetramers for identification of CD4+ T cells. J Immunol Methods 2002; 268: 71-81.
27. Jansson UH, Gudjonsdottir AH, Ryd W et al. Two different doses of gluten show a dose-dependent response of enteropathy but not of serological markers during gluten challenge in children with coeliac disease. Acta Paediatr 2001; 90: 255-9. (Pubitemid 32299542)
28. Kobbevik K. Åpen provokasjon med gluten hos behandlede c liakere og friske kontrollpersoner. Master Thesis, Department of Nutrition, University of Oslo, 2002.
29. http://www.uptodate.com/online/content/topic.do?topicKey=mal-synd/ 5722 & selectedTitle=4%7E150 & source=search-result # H12 (uptodate CD. Up-to-date 2010).
30. Marsh MN, Loft DE, Garner VG et al. Time/dose responses of coeliac mucosae to graded oral challenges with Frazer's fraction III of gliadin. Eur J Gastroenterol Hepatol 1992; 4: 667-73.
31. Ciclitira PJ, Evans DJ, Fagg NL et al. Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) 1984; 66: 357-64. (Pubitemid 14187501)
32. Sturgess R, Day P, Ellis HJ et al. Wheat peptide challenge in coeliac disease. Lancet 1994; 343: 758-61. (Pubitemid 24098692)
33. Fraser JS, Engel W, Ellis HJ et al. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 2003; 52: 1698-702. (Pubitemid 37510388)
34. Tye-Din JA, Anderson RP, Ffrench RA et al. The Effects of ALV003 predigestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol 2010; 134: 289-95.
35. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-33.
36. Rubio-Tapia A, Rahim MW, See JA et al. Mucosal Recovery and Mortality in Adults With Celiac Disease Aft er Treatment With a Gluten-Free Diet. Am J Gastroenterol 2010; 105: 1412-20.